penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Charles M. Vollmer, Jr., M.D.
Gastrointestinal Surgery

 
  • Profile Home
  • Appointments
  • Education
  • Memberships
  • Research
  • Publications

Administrative Office:
Hospital of the University of Pennsylvania
3400 Spruce Street
4 Silverstein Pavilion
Philadelphia, Pennsylvania 19104
Administrative Assistance: Denise Orr
Administrative Telephone: 215-349-8516
Administrative Fax: 215-349-8195

Clinical Office:
Perelman Center for Advanced Medicine
GI Surgery
West Pavilion, 4th Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104

Contact Information (internal use only)

charles.vollmer@uphs.upenn.edu

 

Dr. Charles Vollmer became the Director of Pancreatic Surgery at the University of Pennsylvania in 2011 after initiating his career at the Beth Israel Deaconess Medical Center in Boston where he served as an Assistant Professor of Surgery at Harvard Medical School. He specializes in Pancreaticobiliary and other complex gastrointestinal surgery with a research focus in clinical outcomes assessment in high-acuity surgery. He has authored over 80 manuscripts and numerous book chapters focusing on pancreaticobiliary diseases. He is active in multiple national and regional surgical societies where he has served in various leadership positions including Membership Chairman and Program Chairman of the AHPBA, where he also sits on the Executive Committee. He is currently a reviewer for over 20 surgical specialty journals and is on the Editorial Boards of HPB, the Journal of Gastrointestinal Surgery, and the Journal of Surgical Oncology. In 2008, he was honored as the Josef Fischer Traveling Fellow in Academic Surgery for the Society of Surgery of the Alimentary Tract (SSAT) – an opportunity which allowed him to tour many of the top pancreatic surgical programs in Europe. He also has a sincere interest in medical education and has been a member of the BIDMC Resource Faculty (a dedicated institutional education task-force) as well as a Rabin Fellow in Medical Education. He has received numerous awards from Harvard Medical School for teaching both graduate and undergraduate students.

Dr. Vollmer’s collegiate education was at the University of North Carolina at Chapel Hill. He then received his MD degree in 1994 from Jefferson Medical College in his hometown of Philadelphia. From there he received general surgical training at the Barnes-Jewish Hospital program at the Washington University of St. Louis where he was elected into Alpha Omega Alpha. He studied gene therapy as a surgical oncology research fellow at the University of California, Los Angeles (UCLA) in the middle of his clinical training. After Chief Residency at Washington University, he matriculated to the internationally acclaimed Hepatobiliary and Solid Organ Transplantation Surgery Fellowship at the University of Toronto in 2001. Following another dedicated year of translational research investigating the genetics of pancreatic cancer at the Samuel Leuenfeld Institute in Toronto, he took his first faculty position at BIDMC in 2003.

His current practice at Penn encompasses both malignant and benign conditions of the pancreas and biliary system with a strong emphasis in care of pancreatitis. He provides comprehensive care for patients with pancreatic cystic lesions and also provides education and screening for patients who are at high risk for developing pancreatic cancer. As Co-Chief of Upper Gastrointestinal Oncology at the Abramson Cancer Center, he’ll coordinate clinical and basic science collaborations for pancreatic cancer and is involved in developing novel multidisciplinary approaches to UGI malignancies. He also serves as Co-Director of the Penn Pancreatic Cyst Program – a coordinated multidisciplinary center for managing patients who have pancreatic cysts.

 
Faculty Appointments
2003 - 2006 Instructor of Surgery
Harvard Medical School
Boston, Massachusetts
 
2006 - 2011 Assistant Professor of Surgery
Harvard Medical School
Boston, Massachusetts
 
2011 - present Associate Professor of Surgery
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
 
Hospital and Administrative Appointments
2003 - 2011 Attending Surgeon
Beth Israel Deaconess Medical Center
Boston, Massachusetts
 
2005 - 2009 Resource Faculty - Multidisciplinary Education Task Force
Beth Israel Deaconess Medical Center
Boston, Massachusetts
 
2004 - 2007 Medical Director for CC6 Surgical Floor
Beth Israel Deaconess Medical Center
Boston, Massachusetts
 
2007 - 2011 Quality Assurance/JCAHO Readiness Monitor, Department of Surgery
Beth Israel Deaconess Medical Center
Boston, Massachusetts
 
2011 - present Attending Surgeon
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
2011 - present Active Surgeon
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
 
2011 - present Active Surgeon
Pennsylvania Hospital
Philadelphia, Pennsylvania
   
2011 – Present Clinical Excellence Advisory Board
University of Pennsylvania
   
2012 – Present Co-Director Penn Pancreatic Cyst Program
 
Other Appointments
1989 - 1990 Laboratory Research Assistant
Institute for Cancer Research
Fox Chase Cancer Center
Department of Surgical Oncology
Philadelphia, Pennsylvania
 
2005 - 2011 Member, Dana Farber/ Harvard Cancer Center (DF/HCC)
Boston, Massachusetts
   
2005 - present Member, National Ultrasound Faculty, American College of Surgeons
   
2012  Associate Examiner, American Board of Surgery
 
Education/Training
1985 - 1989 B.A. University of North Carolina (Chemistry)
Chapel Hill, North Carolina
 
1990 - 1994 M.D. Jefferson Medical College
of Thomas Jefferson University
Philadelphia, Pennsylvania
 
Postgraduate Training and Fellowship Appointments
1994 - 1995 Intern in General Surgery
Barnes-Jewish Hospital
Washington University School of Medicine
St. Louis, Missouri
 
1995 - 1996 Junior Resident in General Surgery
Barnes-Jewish Hospital
Washington University School of Medicine
St. Louis, Missouri
 
1996 - 1998 Research Fellow in Surgical Oncology
UCLA School of Medicine
Los Angeles, California
 
1998 - 2000 Senior Resident in General Surgery
Barnes-Jewish Hospital
Washington University School of Medicine
St. Louis, Missouri
 
2000 - 2001 Chief Resident in General Surgery
Barnes-Jewish Hospital
Washington University School of Medicine
St. Louis, Missouri
 
2001 - 2002 Clinical Fellow in Hepatobiliary and
GI Transplantation Surgery
Toronto General Hospital
University of Toronto, Toronto, ON Canada
 
2002 - 2003 Research Fellow in Hepatobiliary Oncology
Samuel Lunenfeld Research Institute
University of Toronto, Toronto, ON Canada
 
2006 - 2007

Rabkin Fellow in Medical Education
Shapiro Institute for Education
Beth Israel Deaconess Medical Center
Harvard University
Boston, Massachusetts

 
Memberships/Societies
 
National/International Societies
  • St. George’s Society/American Cancer Society (1990 - 1992)
  • American College of Surgeons (Fellow, 2005 - present)
    • Member of the Cancer Care Standards Development Committee (Pancreas Module)
  • Society for Surgery of the Alimentary Tract (1999 - present)
    • Patient Care Committee (2004 - 2007)
    • Program Committee (Hepatic-Biliary Subcommittee)
      (2005 - 2007)
    • Program Committee (Pancreatic Subcommittee)
      (2008 - 2011)
    • Education Committee (2010 - pesent)
  • American Hepato-Pancreato-Biliary Association (AHPBA)
    (2000 – present)
    • Membership Committee (2005 - 2010)
      • Co-Chairman (2007 - 2008)
      • Chairman (2008 - 2010)
    • Program Committee (2006 - 2008 and 2010 - present)
      • Vice-Chairman (2010 - 2011)
      • Chairman (2011 - 2012)
    • Executive Council (2008 - present)
  • American Association for Cancer Research (2001 -2009)
  • The Pancreas Club (2002 - present)
    • Program Committee (2007 - 2009)
  • The Canadian Hepato-Pancreatico-Biliary Club (2003 -2005)
  • International Hepato-Pancreato-Biliary Association (IHPBA)
    (2003 - present)
    • Program Committee (2012-2014)
  • Association for Academic Surgery (2005 - 2009)
    • Institutional Representative for BIDMC (2007 - 2009)
  • International Association of Pancreatology (2005 - 2011)
  • Society of University Surgeons (2009 - present)
    • Institutional Representative for BIDMC (2010 - 2011)
  • National Pancreas Foundation (2010 - present )
    • Board of Directors – Boston Chapter (2011)
  • Surgical Biology Club II (2010 - present)
  • Society of Clinical Surgery (2012-present)
  • International Study Group for Pancreas Surgery (ISGPS) (2012-Present)
Local/Regional Societies
  • John H. Gibbon, Jr. Surgical Society (1990 - 1994)
    • Secretary/Treasurer (1992 - 1993)
    • President (1993 - 1994)
  • Boston Pancreas Study Group (2005 - 2006)
  • Boston Surgical Society (2007 - 2011)
  • New England Surgical Society (2010 - present)
Scientific Committees
  • Pancreas Cancer Rome (2008)
    • Program Committee
  • International Hepato-Pancreato-Biliary Association (IHPBA)
    • Program Committee for 2012 Biennial Meeting – Paris
Editorial Positions
  • American Journal of Surgery, Ad Hoc Reviewer
  • Journal of the American College of Surgeons, Ad Hoc Reviewer
  • Cancer, Ad Hoc Reviewer
  • Annals of Surgery, Ad Hoc Reviewer
  • Journal of Surgical Oncology, Editorial Board
  • Digestive Diseases and Sciences, Ad Hoc Reviewer
  • Journal of the Pancreas (JOP), Ad Hoc Reviewer
  • Surgery, Ad Hoc Reviewer
  • Annals of Surgical Oncology, Ad Hoc Reviewer
  • CA: A Cancer Journal for Clinicians, Ad Hoc Reviewer
  • Journal of Gastrointestinal Surgery (JOGS), Editorial Board
  • HPB Surgery, Ad Hoc Reviewer
  • HPB, Editorial Board
  • Southern Medical Journal, Ad Hoc Reviewer
  • Hospital Practice, Ad Hoc Reviewer
  • Digestive Surgery, Ad Hoc Reviewer
  • International Journal of Surgical Oncology, Ad-hoc Reviewer
  • Hepatobiliary and Pancreatic Diseases International, Ad-hoc Reviewer
  • The Oncologist, Ad-hoc Reviewer
  • World Journal of Surgery, Ad-hoc Reviewer
  • Pancreas, Ad-hoc Reviewer
  • British Journal of Surgery, Ad-hoc Reviewer
 
Research
1996 - 1998 Generation of Tumor Immunity Using Genetically Engineered Dendritic Cells (UCLA)
 
1997 - 1998 Dendritic Cell Genetic Immunization Using Alpha-fetoprotein As A Tumor-Associated Antigen for Hepatocellular Carcinoma (UCLA)
 
2002 - 2003 Characterization of a Novel Translocation Breakpoint in Pancreatic Cancer (Toronto)
 
2005 - 2006 Outcomes Research In Pancreaticobiliary Surgery
(BIDMC - Boston)
 
2011 A Phase III Study of Chemotherapy and Chemoradiotherapy with or without HyperAcute®-Pancreatic Cancer Vaccine in Subjects with Surgically Resected Pancreatic Cancer (BIDMC - Boston)
 
2011 - present Outcomes and systems analysis in high-activity surgery (Univ. of Penn)
   
2011 – present Faculty Mentor for Harrison Clinical Research Fellows
   
2011 – present Co investigator for Stand Up To Cancer (SU2C) pancreas research
   
2012 – present Local PI for Randomized, Controlled clinical trial investigating the value of intraabdominal drain placement following pancreatic resection
   
2012 – present

Primary PI on a multicenter (9) study to determine the Postoperative Morbidity Index (PMI) for Pancreatectomy

   
2012 – present

Primary PI on a multicenter (12) study to assess variance in pancreatic fistula risk and occurrence

 
Publications
 
Research Publications, Peer Reviewed
  1. Yeung RS, Vollmer CM, Taylor DD, Palazzo J, Weese JL. Intratumoral rIL2-based immunotherapy in B16 melanoma. Journal of Surgical Research 1992 Aug.; 53(2):203-210.
  2. Ribas A, Butterfield LH, McBride WH, Jilani S, Bui LA, Vollmer CM, Lau R, Dissette VB, Hu W, Chen A, Glaspy J, Economou JS. Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Research 1997 July 15; 57(14):2865-2869.
  3. Ribas A, Bui LA, Butterfield LH, Vollmer CM, Jilani SM, Dissette VB, Glaspy JA, McBride WH, Economou JS. Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities. Anticancer Research 1999 Mar-Apr; 19(2A):1165-1170.
  4. Vollmer CM, Eilber FC, Butterfield LH, Ribas A, Dissette VB, Koh A, Montejo L, Lee MC, Andrews KJ, McBride WH, Glaspy JA, Economou JS. ?-Fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. Cancer Research 1999 July 1; 59: 3064-3067.
  5. Butterfield LH, Koh A, Meng W, Vollmer CM, Ribas A, Dissette VB, Lee E, Glaspy JA, McBride WH, Economou JS. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from ?-fetoprotein. Cancer Research 1999 July 1; 59(13):3134-3142.
  6. Vollmer CM, Ribas A, Butterfield LH, Dissette VB, Andrews KJ, Eilber FC, Montejo LD, Chen AY, Hu B, Glaspy JA., McBride WH, Economou JS. p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma. Cancer Research 1999 Sept. 1; 59(17):4369-4374.
  7. Ribas A, Butterfield LH, McBride WH, Dissette VB, Koh A, Vollmer CM, Hu B, Chen AY, Glaspy JA, Economou JS. Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells. Cancer Gene Therapy 1999 Nov-Dec; 6(6):523-536.
  8. Andrews KJ, Ribas A, Butterfield LH, Vollmer CM, Eilber FC, Dissette VB, Nelson SD, Shintaku P, Mekhoubad S, Nakayama T, Taniguchi M, Glaspy JA, McBride WH, Economou JS. Adenovirus-IL-12 mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer-T cells. Cancer Research 2000 Nov. 15; 60(22):6457-6464.
  9. Vollmer CM, Schmeig RE, Balfe DM, Freeman BD. Traumatic colonic hematoma. Journal of Trauma 2000 Dec.; 49(6):1155.
  10. Butterfield LH, Meng WS, Koh A, Vollmer CM, Ribas A, Dissette VB, Faull K, Glaspy JA, McBride WH, Economou JS. T cell responses to HLA-A*0201-restricted peptides derived from human ? fetoprotein. Journal of Immunology 2001 Apr. 15; 166(8):5300-5308.
  11. Vollmer CM, Flye MW. Bronchoesophageal fistula secondary to broncholithiasis. American Journal of Surgery 2001 June; 181(6):562-563.
  12. Vollmer CM, Drebin JA, Middleton WD, Teefey SA, Soper NJ, Eagon CJ, Linehan DC, Strasberg SM. Utility of staging laparoscopy in different subsets of peripancreatic and biliary malignancies. Annals of Surgery 2002 Jan.; 235(1):1-7.
  13. Dixon E, Vollmer CM, Greig PD, Gallinger S. HPB clinics around the world: The University of Toronto HPB Program at the Toronto General Hospital. HPB 2003; 5(1):39-42.
  14. Dixon E, Sutherland FR, Vollmer CM, Greig PD. Bile duct injury following laparoscopic cholecystectomy: Resection of the entire extrahepatic/pancreatic tree. Journal of the American College of Surgeons 2003 Nov.; 197(5):862-863.
  15. Vollmer CM, Dixon E, Grant DR. Management of a solid-pseudopapillary tumor of the pancreas with liver metastases. HPB 2003; 5:264-267.
  16. Sahajpal AK, Vollmer CM, Pollett A, Gallinger S. Sclerosing pancreatitis presenting as a periampullary tumor. HPB 2003; 5:268-272.
  17. Dixon E, Vollmer CM, Sahajpal AK, Cattral MS, Greig PD. Multipurpose incision for hepatobiliary surgery. American Journal of Surgery 2004 Jan.; 187(1):128-130.
  18. Cattral MS, Molinari M, Vollmer CM, McGilvray I, Wei A, Walsh M, Marks N, Lilly L, Girgrah N, Levy G, Greig PD, Grant DR. Living-donor right hepatectomy with or without inclusion of the middle hepatic vein: Comparison of morbidity and outcomes in 56 patients. American Journal of Transplantation 2004 May; 4(5):751-757.
  19. Ball CG, Gmora S, Vollmer CM, Dixon E. An intraluminal lesion in the mid-common bile duct and right hepatic duct causing right portal vein obstruction. Journal of Hepatology 2004 Dec.; 41(6):1060.
  20. Dixon E, Vollmer CM, Bathe O, Sutherland F. Training, practice and referral patterns in hepatobiliary and pancreatic surgery: Survey of general surgeons. Journal of Gastrointestinal Surgery 2005 Jan.; 9(1):109-114.
  21. Dixon E, Vollmer CM, Sahajpal AK, Cattral MS, Grant DR, Taylor BR, Langer B, Greig PD, Gallinger S. Improved survival with aggressive surgical resection for gallbladder cancer: A twelve-year experience. Annals of Surgery 2005 Mar.; 241(3):385-394.
  22. Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP. Predominant Bcl-XL knockdown disables anti-apoptotic mechanisms: TRAIL-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Cancer Research. 2005 Mar. 15; 65(6):2344-2352.
  23. Dixon E, Vollmer CM, Sahajpal A, Cattral MS, Grant DR, Taylor BR, Langer B, Gallinger S, Greig PD. Transduodenal resection of peri-ampullary lesions. World Journal of Surgery 2005 May; 29(5):649-652.
  24. Karmali S, Vollmer CM, Bathe O, Pasieka JL, Sutherland F, Dixon E. The current status of hepatobiliary and pancreatic surgical literature. HPB 2005; 7(4):313-315.
  25. Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, Taylor BR, Grant DR, Vollmer CM. Factors associated with early recurrence after resection for HCC and outcomes. Journal of the American College of Surgeons 2006 Feb.; 202(2):275-283.
  26. McKay A, Mackenzie S, Sutherland FR, Bathe OF, Doig C, Dort J, Vollmer CM, Dixon E. Meta-analysis of pancreaticojejunostomy vs. pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. British Journal of Surgery 2006 Aug.; 93(8):929-936.
  27. Vollmer CM, Dixon E, Sahajpal A, Cattral MS, Grant DR, Gallinger S, Taylor BR, Greig PD. Water-jet dissection for parenchymal division during hepatectomy. HPB 2006; 8(5):377-385.
  28. Pratt W, Maithel SK, Vanounou T, Callery MP, Vollmer CM. Postoperative pancreatic fistulas are not equivalent after proximal, distal and central pancreatic resections. Journal of Gastrointestinal Surgery 2006 Nov; 10(9):1264-1279.
  29. Maithel SK, Khalili K, Dixon E, Guindi M, Callery MP, Cattral MS, Taylor BR, Gallinger S, Greig PD, Grant DR, Vollmer CM. Impact of regional lymph node evaluation in staging patients with periampullary tumors. Annals of Surgical Oncology 2007 Jan; 14(1):202-210.
  30. Sahajpal A, Vollmer CM, Dixon E, Chan EK, Wei A, Cattral MS, Taylor B, Grant DR, Greig PD, Gallinger S. Chemotherapy prior to liver resection for colorectal cancer hepatic metastases does not adversely affect perioperative outcomes. Journal of Surgical Oncology 2007 Jan; 95(1): 22-27.
  31. Pratt W, Maithel SK, Vanounou T, Huang Z, Callery MP, Vollmer CM. Clinical and economic validation of the International Study Group of Pancreatic Fistula (ISGPF) Classification Scheme. Annals of Surgery 2007 Mar.; 245(3):443-451.
  32. Vollmer CM, Pratt W, Vanounou T, Maithel SK, Callery MP. Quality assessment in high-acuity surgery: Volume and mortality are not enough. Archives of Surgery 2007 Apr.; 142(4):371-380.
  33. Vanounou T, Pratt W, Fischer JE, Vollmer CM, Callery MP. Deviation based cost modeling (DBCM): A novel model to evaluate the clinical and economic impact of clinical pathways. Journal of the American College of Surgeons 2007 Apr.; 204(4):570-579.
  34. Brennan DD, Zamboni G, Sosna J, Callery MP, Vollmer CM, Raptopoulos VD, and Kruskal JB. Virtual Whipple: preoperative surgical planning with volume-rendered MDCT images to identify arterial variants relevant to the Whipple procedure. AJR American Journal of Roentgenology 2007 May; 188(5):W451-455.
  35. Zamboni G, Kruskal JB, Vollmer CM, Baptista J, Callery MP, Raptopoulos VD. Pancreatic adenocarcinoma: Value of multidetector CT angiography in preoperative evaluation. Radiology 2007 Dec; 245(3):770-778.
  36. Maithel SK, Pratt W, Kelleher T, Avigan D, Goldman H, Pfeifer W, Pihan GA, Vollmer CM. Autoimmune pancreatitis in the setting of Castleman’s Disease. Pancreas 2007 Nov; 35(4):384-38.
  37. Vanounou T, Pratt W, Callery MP, Vollmer CM. Selective administration of prophylactic octreotide during pancreatoduodenectomy: A clinical and cost-benefit analysis in low- and high-risk glands. Journal of the American College of Surgeons 2007 Oct; 205(4):546-557.
  38. Pratt W, Joseph S, Callery MP, Vollmer CM. POSSUM accurately predicts morbidity in pancreatic resection. Surgery 2008 Jan; 143(1):8-19.
  39. Pratt W, Callery MP, Vollmer CM. Risk prediction for development of pancreatic fistula utilizing the ISGPF classification Scheme. World Journal of Surgery 2008 Mar; 32(3):419-428.
  40. Schaberg FJ Jr, Doyle MB, Chapman WC, Vollmer CM, Zalieckas JM, Birkett DH, Miner TJ, Mazzaglia PJ. “Incidental Lesions of the Pancreas” in Incidental Findings at Surgery – Part 1. Current Problems in Surgery, 2008 May; 45(5):325-374.
  41. Pratt W, Steinbrook RA, Maithel SK, Vanounou T, Callery MP, Vollmer CM. Epidural analgesia in pancreaticoduodenectomy: A critical appraisal. Journal of Gastrointestinal Surgery 2008 July; 12(7):1207-1220.
  42. Pratt WB, Callery MP, Vollmer CM. Optimal surgical performance attenuates physiologic risk in high-acuity surgery. Journal of the American College of Surgeons 2008 Nov.; 207(5):717-730.
  43. Sachs T, Pratt WB, Callery MP, Vollmer CM. The incidental asymptomatic pancreatic lesion: Nuisance or threat? Journal of Gastrointestinal Surgery 2009 Mar.; 13(3):405-415 (Epub Jan 8th, 2009).
  44. Kakoza RM, Vollmer CM, Stuart KE, Takoudes T, Hanto DW. Pancreatic adenocarcinoma in the pregnant patient: A case report and literature review. Journal of Gastrointestinal Surgery 2009 Mar; 13(3):535-541 (Epub Sep 25, 2008).
  45. Pratt WB, Vollmer CM, Callery MP. Outcomes in pancreatic resection are negatively influenced by preoperative hospitalization. HPB 2009; 11(1):57-65.
  46. Demirjian AN, Vollmer CM, McDermott DF, Atkins MB, Callery MP. Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas. HPB 2009; 11(2):150-153.
  47. Vollmer CM. Unexpected identification of gallbladder carcinoma during cholecystectomy. Journal of Gastrointestinal Surgery 2009 Nov.; 13(11):2034-2036 (Epub Feb 24, 2009).
  48. Sawhney MS, Devarajan S, O’Farrel P, Cury M, Kundu R, Vollmer CM, Brown A, Chuttani R, Pleskow DK. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid. Gastrointestinal Endoscopy 2009 May; 69(6):1106-1110 (Epub Feb 26, 2009).
  49. Evans DB, Farnell MB, Lillemoe KD, Vollmer CM, Strasberg SM, Schulick RD. Surgical treatment of resectable and borderline resectable pancreas cancer: Expert consensus statement. Annals of Surgical Oncology 2009 July; 16(7):1736-1744 (Epub Apr 23).
  50. Pratt WB, Callery MP, Vollmer CM. The latent presentation of pancreatic fistulae. British Journal of Surgery 2009 May 11; 96(6):641-649.
  51. Hueman MT, Vollmer CM, Pawlik TM. Evolving treatment strategies for gallbladder cancer. Annals of Surgical Oncology 2009 Aug; 16(8):2101-2115 (Epub June 3rd).
  52. Pratt WB, Gangavati A, Agarwal K, Schreiber R, Lipsitz LA, Callery MP, Vollmer CM. Establishing standards of quality for outcomes of elderly patients undergoing pancreatic resection. Archives of Surgery 2009 Oct; 144(10): 950-956.
  53. Sawhney MS, Al-Bashir S, Cury MS, Brown A, Chuttani R, Pleskow DK, Callery MP, Vollmer CM. International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas. Clinical Gastroenterology and Hepatology 2009 Dec.; 7(12):1373-1376 (Epub July 1).
  54. McMahon C, Vollmer CM, Goldsmith J, Brown A, Pleskow D, Pedrosa I. An unusual variant of anomalous pancreaticobiliary junction in a patient with pancreas divisum diagnosed with secretin-magnetic resonance cholangiopancreatography. Pancreas 2010 Jan.; 39(1):101-104.
  55. Kent TS, Raptopoulos V. Callery MP, Gatum S, Vollmer CM. Escalating computed tomography angiogram (CTA) grade predicts unresectability and margin status for pancreaticobiliary neoplasms. HPB 2010; 12(2):115-112 (Epub Jan 26).
  56. Mahadevan A, Jain S, Goldstein M, Miksad R, Pleskow DK, Sawhney MS, Brennan D, Callery MP, Vollmer CM. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. International Journal of Radiation Oncology, Biology Physics 2010 Nov 1; 78(3):735-742 (Epub 2010 Feb 18).
  57. Odell D, Pratt WB, Callery MP, Vollmer CM. The obstructed pancreatico-biliary drainage limb: Presentation, management and outcomes. Journal of Gastrointestinal Surgery 2010 Sep; 14(9):1414-1421 (Epub 2010 Jun 22).
  58. Dimerjian AN, Kent TS, Callery MP, Vollmer CM. The inconsistent nature of symptomatic pancreatico-jejunostomy anastomotic strictures. HPB 2010 Sep.; 12(7):482-487.
  59. Kent TS, Callery MP, Vollmer CM. The Bridge-stent technique for salvage of pancreatico- jejunal anastomotic dehiscences. HPB 2010 Oct; 12(8):577-582. doi: 10.1111/j.1477-2574.2010.00227.x.)
  60. Dubay DA, Sandroussi C, Kachura JR, Ho CS, Beecroft JR, Vollmer CM, Sherman M, Ghanekar A, Guba M, Cattral MS, McGilvray ID, Grant DR, Greig PD. Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantion? HPB 2011 Jan; 13(1):24-32. doi: 10.1111/j.1477-2574.2010.00228.x. Epub 2010 Nov 8.
  61. Kent TS, Vollmer CM, Callery MP. IPMN and the pancreatic incidentaloma. World Journal of Gastrointestinal Surgery 2010 2(10):319-323.
  62. Vollmer CM, Newman L, Huang G, Irish J, Hurst J, and Horvath K. Perspectives on intraoperative teaching: Divergence and convergence between learner and teacher. Journal of Surgical Education 2011;68(6) 485-494.
  63. Kent TS, Sachs TE, Callery MP, and Vollmer CM. Readmission after major pancreatic resection: A necessary evil? Journal of the American College of Surgeons Oct;213(4):515-23. Epub 2011 Aug 16.
  64. Kent TS, Vollmer CM, Sachs T, Sanchez N, and Callery MP. Conditional survival for resected pancreatic adenocarcinoma: Better than expected. HPB 2011 13(12):876-80. Epub Sept 16.
  65. Mahadevan A, Miksad R, Goldstein M, Sullivan R, Bullock A,  Buchbinder E, Pleskow D, Sawhney M, Kent T, Vollmer CM, and Callery MP. Induction gemcitabine and stereotactic body radiotherapy (GEM-SBRT-GEM) for locally advanced non-metastatic pancreas cancer. International Journal of Radiation Oncology, Biology, Physics 2011 Epub Jun 8.
  66. Vollmer CM, Sanchez NJ, Christein JD, Kent TS, and Callery MP. A Root-Cause Analysis of Mortality Following Major Pancreatectomy. Journal of Gastrointestinal Surgery 2012 Jan;16(1):89-102; discussion 102-3. Epub 2011 Nov 8.
  67. Nadig S, Goldsmith J, Pedrosa I, Callery MP, and Vollmer CM. Clinical implications of non-neoplastic mucinous cysts of the pancreas. Pancreas 2012 Apr;41(3):441-6. Epub Oct 19, 2011.
  68. Grendar J, Shaheen AA, Myers RP, Parker R, Vollmer CM, Ball CG, Quan ML, Kaplan GG, and Dixon E. Predicting in-hospital mortality in patients undergoing complex gastrointestinal surgery: Determining the optimal risk-adjustment methodology. Archives of Surgery 2012 Feb;147(2):126-35. Epub 2011 Oct 17.
  69. Newman LR, Brodsky DB, Roberts DH, Pelletier SR, Johansson AC, Vollmer CM, Atkins KM, and Schwartzstein RM. Developing expert-derived rating standards for the peer assessment of lectures. Academic Medicine 2012; 87: 356–363.
  70. Kent TS, Gautum S, Callery MP, and Vollmer CM. The Burden of Infection for Elective Pancreatic Resections. Surgery 2013;153(1):86-94. Epub June 13, 2012.
  71. Dellinger EP, Forsmark CE, Layer P, Levy P, Maravi-Poma E, Petrov MS, Shimosegawa T, Siriwardena AK, Uomo G, Whitcomb DC, and Windsor JA. Determinant-Based Classification of Acute Pancreatitis Severity: An International Multidisciplinary Consultation. Annals of Surgery Epub August 8, 2012
  72. Callery MP, Pratt WB, Kent TS, Chaikof E, and Vollmer CM. A Prospectively Validated Risk Score Model for Pancreatic Fistula after Pancreaticoduodenectomy. Journal of the American College of Surgeons 2013;216(1):1-14. Epub Nov 2, 2012.
  73. Kalish BT, Vollmer CM, Kent TS, Nealon W, Tseng JF, and Callery MP. Quality Assessment In Pancreatic Surgery: What Might Tomorrow Require? Journal of Gastrointestinal Surgery 2013 Jan;17(1):86-93.Epub Nov 6, 2012
  74. Lewis RS and Vollmer CM. Risk Scores and Prognostic Models in Surgery: Pancreas Resection as a Paradigm. Current Problems in Surgery 2012;49(12):731-95.
  75. Nimhuircheartaigh J, Sun M, Callery MP, Siewert B, Vollmer CM, Kane R. Pancreas Surgery: A Multidisciplinary Assessment of the Value of Intraoperative Ultrasound Radiology 2013 Mar;266(3):945-55. Epub Dec 6 2012
  76. Lewis RS, Drebin JA, Callery MP, Fraker D, Kent TS, Gates J, and Vollmer CM. A Contemporary Analysis of Survival for Resected Pancreatic Ductal Adenocarcinoma. HPB 2013 Jan;15(1):49-60. Epub Sep 24, 2012.
  77. Glass CC, Gondek SP, Vollmer CM, Callery MP, and Kent TS. Readmission following Pancreatectomy: What Can Be Improved? HPB 2013Epub Mar 12, 2013.
  78. Sachs TE, Kent TS, Pratt WB, Callery MP, Vollmer CM. The Pancreatico-Jejunal Anastomotic Stent: Friend or Foe? Surgery 2013 May;153:651-62. Epub Jan 7, 2013.
  79. Miller BC, Christein JD, Behrman SW, Callery MP, Kent TS, Pratt WB, Drebin JA, and Vollmer CM. Assessing the Impact of Fistulas after Pancreaticoduodenectomy Using Quantitative Severity Weighting. HPB 2013 (Manuscript in Press)
  80. Miller BC, Christein JD, Behrman SW, Drebin JA, Pratt WB, Callery MP, and Vollmer CM. A Multi-Institutional External Validation of the Fistula Risk Score for Pancreatoduodenectomy. Journal of Gastrointestinal Surgery 2013 (Manuscript in Press).
  81. Hurdle V, Ouellet JF, Dixon E, Howard TJ, Lillemoe KD, Vollmer CM, Sutherland FR, and Ball CG. Does Regional Variation Impact Decision Making in the Management and Palliation of Pancreatic Head Adenocarcinoma: Results From an International Survey. Canadian Journal of Surgery 2013 (Manuscript in Press).
Reviews in Peer Reviewed Research Publications
  1. Dixon E, Vollmer CM, Bathe O, Sutherland F. Vascular occlusion to reduce blood loss during hepatic resection. [Review] American Journal of Surgery 2005; 190:75-86.
  2. Callery MP, Pratt WB, Vollmer CM. Prevention and management of pancreatic fistula. Journal of Gastrointestinal Surgery 2009; 13(1):163-173.
  3. Cannon JW, Callery MP, Vollmer CM. Diagnosis and management of pancreatic pseudocysts: What is the evidence? Journal of the American College of Surgeons 2009; 209(3): 385-393 (Epub Jun 18, 2009).
  4. Vollmer CM, Dixon E. IPMN…Coming of age. World Journal of Gastrointestinal Surgery 2010 2(10):299-305.
  5. Lee MK and Vollmer CM. The Current State of Minimally-Invasive Distal Pancreatectomy. Current Surgery Reports (In Press)
  6. Vollmer CM.The Economics of Pancreas Surgery. Surgery Clinics of North America 2013 Jun;93(3):711-28. Epub 2013 Mar 25.
Contributions to Peer-Reviewed Clinical Research Publications, Participation Cited but not by Authorship
  1. Reid-Lombardo KM, Farnell MB, Crippa S, Barnett M, Maupin G, Bassi C, Traverso LW and members of the Pancreatic Anastomotic Leak Study Group. Pancreatic anastomotic leakage after pancreaticoduodenectomy in 1507 patients: A report from the pancreatic anastomotic leak study group. Journal of Gastrointestinal Surgery 2007; 11: 1451-1459. (Vollmer C: participant in PALSG)
  2. Pancreatic Disorders: State of the Science and Future Directions The National Pancreas Foundation Pancreas 2007; 35 (3):276-280. (Vollmer C: participant in Workshop Study Group)
Abstracts (Past 3 Years)
  1. Sanchez N, Gondek S, Kent TS, Callery MP, Vollmer CM. Marked variance between estimated and calculated blood loss for major pancreatic resections. Oral Presentation at the American Hepato-Pancreato-Biliary Annual Congress, Miami, FL, Mar. 12, 2011.
  2. Kent TS, Sachs T, Sanchez N, Vollmer CM, Callery MP. Conditional survival for resected pancreatic adenocarcinoma: Better than expected. Oral presentation at the American Hepato-Pancreato-Biliary Annual Congress, Miami, FL, Mar. 13, 2011.
  3. Vollmer CM, Newman L, Huang G, Irish J, Hurst J, Horvath K. Perspectives on intraoperative teaching: Divergence between learner and teacher. Oral Presentation at the Association of Program Directors in Surgery (APDS) Annual Meeting, Boston, MA, Mar. 25th 2011.
  4. Interdisciplinary team training in simulation to enhance communication and patient safety in the OR. 4th Annual Silverman Institute Symposium on Quality and Safety. Beth Israel Deaconess Medical Center. March 29, 2011.
  5. Vollmer CM, Sanchez NJ, Kent TS, Callery MP. A root-cause analysis of mortality following major pancreatectomy. Oral presentation at the SSAT 52nd Annual meeting for Digestive Disease Week. Chicago, IL. May 10, 2011. Also at The Pancreas Club – 45th Annual Meeting. Chicago, IL. May 7, 2011.
  6. Callery MP, Pratt WB, Sanchez N, Kent TS, Chaikof E, and Vollmer CM. A prospectively validated risk score model for pancreatic fistula after pancreaticoduodenectomy. American College of Surgeon’s 97th Annual Meeting; San Francisco, CA October 2011. (Accepted for oral presentation)
  7. Nimhuircheartaigh J, Sun M, Callery MP, Sanchez N, Siewert B, Vollmer CM, Kane R. Value of intra-operative ultrasound for the performance of pancreatic surgery: a multidisciplinary assessment. RSNA Chicago, IL, Nov, 2011. (Abstract in Submission)
  8. ewis RS, Drebin JA, Callery MP, Fraker D, Kent TS, Gates J, and Vollmer CM. Dissecting survival for pancreatic ductal adenocarcinoma (PDAC) in the contemporary era. Oral Presentation at the American Hepato-Pancreato-Biliary Annual Congress. Miami, FL March 10, 2012, and Oral Presentation at the 10th World Congress of the International Hepato-Pancreato-Biliary Association IHPBA. Paris, France, July 2012.
  9. Gondek S, Glass C, Vollmer CM, Callery MP, and Kent TS. Readmission following pancreatectomy: What can we do better? Oral Presentation at the 10th World Congress of the International Hepato-Pancreato-Biliary Association IHPBA. Paris, France, July 2012, and the Pancreas Club 46th Annual Meeting. San Diego, CA, May 2012.  Poster presentation at the American Hepato-Pancreato-Biliary Annual Congress. Miami, FL March 9, 2012.
  10. Lewis RS, Drebin JA, Callery MP, Kent, TS, Fraker D, Gates J,  and Vollmer CM. Failure to receive adjuvant therapy following resection for pancreatic cancer: patterns and implications. Poster presentation at the SSAT 53nd Annualmeeting for Digestive Disease Week. San Diego, CA May 22, 2012 and the Pancreas Club 46th Annual Meeting. San Diego, CA, May 18, 2012.
  11. Kalish BT, Vollmer CM, Kent TS, Nealon W, Tseng JF, and Callery MP. Quality assessment in pancreatic surgery: What might tomorrow require? Oral Presentation at the SSAT 53nd Annualmeeting for Digestive Disease Week. San Diego, CA May 2012 and the Pancreas Club 46th Annual Meeting. San Diego, CA, May 2012.
  12. Lewis RS, Drebin JA, Callery MP, Kent, TS, Fraker D, Gates J, and Vollmer CM. Extending the criteria for surgery on “Unresectable” pancreatic cancer. Poster presentation at the 10th World Congress of the International Hepato-Pancreato-Biliary Association IHPBA. Paris, France, July 2012.
  13. Brook OR, Brook A, Vollmer CM, Kent T, Sanchez N, and Pedrosa I. Structured vs. Non-structured Reporting for Pancreatic CTA. Accepted for oral presentation at RSNA, Chicago, IL, November, 2012. Dr. Brook is the recipient of the RSNA Trainee Research Prize
  14. Vollmer CM, Lewis R, Callery MP, Fraker D, Gates J, and Drebin JA. Resected Pancreatic Ductal Adenocarcinoma (PDAC) With Favorable Prognosis: Is Adjuvant Therapy Beneficial? Oral Presentation at the Society of University Surgeons/8th Annual Academic Surgical Congress; New Orleans, LA. Feb 6, 2013.
  15. Miller B, Christein JD, Callery MP, Kent TS, Pratt W, Drebin JA, and Vollmer CM. Assessing the Impact of Fistulas After Pancreaticoduodenectomy Using the Postoperative Morbidity Index (PMI). Oral Presentation at the American Hepato-Pancreato-Biliary Annual Congress. Miami, FL Feb 24, 2013.
  16. Mazer LM, Vollmer CM, Callery MP, and Kent TS. Predictors of Initiation and Completion of Adjuvant Therapy After Surgical Resection for Pancreatic Adenocarcinoma. Oral Presentation at the American Hepato-Pancreato-Biliary Annual Congress. Miami, FL Feb 24, 2013.
  17. Miller BC, Christein JD, Behrman SW, Drebin JA, Pratt WB, Callery MP, and Vollmer CM. A Multicenter External Validation of the Fistula Risk Score for Pancreatoduodenectomy. Oral Presentation at the SSAT Resident’s Research Conference, Orlando, FL May 17 2013; the SSAT 54nd Annualmeeting for Digestive Disease Week, Orlando, FL May 20 2013; and the Pancreas Club 47th Annual Meeting, May 18th, 2013.
  18. Vollmer CM, Lewis RS, Hall BL, Allendorf JD, Beane JP, Behrman SW, Callery MP, Christein JD, Drebin JA, Epelboym I, He J, Pitt HA, Winslow E, Wolfgang C, and Strasberg SM. Comparing the Impact of Complications After Major Pancreatectomies Using the Postoperative Morbidity Index. Oral Presentation at the Pancreas Club 47th Annual Meeting. Orlando, FL, May 17 2013.
  19. Miller BC, Christein JD, Behrman SW, Callery MP, Kent TS, Pratt W, Drebin JA, and Vollmer CM. Assessing the Impact of Fistulas after Pancreaticoduodenectomy Using Quantitative Severity Weighting. Poster Presentation the Pancreas Club 47th Annual Meeting. Orlando, FL, May18, 2013.
  20. Vollmer CM, Lewis RS, Hall BL, Allendorf JD, Beane JP, Behrman SW, Callery MP, Christein JD, Drebin JA, Epelboym I, He J, Pitt HA, Winslow E, Wolfgang C, and Strasberg SM. Establishment of the Postoperative Morbidity Index for Pancreatectomy Using ACS –NSQIP and the Modified Accordion System. Oral Presentation at the Annual ACS-NSQIP Conference. San Diego, CA, July 15, 2013.
  21. Vollmer CM, Lewis RS, Hall BL, Allendorf JD, Beane JP, Behrman SW, Callery MP, Christein JD, Drebin JA, Epelboym I, He J, Pitt HA, Winslow E, Wolfgang C, and Strasberg SM. Establishing a Quantitative Benchmark for Morbidity in Pancreatoduodenectomy Using ACS -NSQIP, the Accordion Severity Grading System and the Postoperative Morbidity Index. Oral Presentation at the American College of Surgeons 99th Annual Meeting, Washington, DC. October 8, 2013.
Editorials, Chapters & Participation in Committee Reports
  1. Vollmer CM, Lowell JA. Nutrition. In Doherty, GM, Meko BM, Olson JA, Peplinski GR, Worrall NK (eds.): Washington Manual of Surgery, 2nd Edition. Philadelphia: Lippincott Williams & Wilkins, 1999, 10-24.
  2. Strasberg SM, Vollmer CM. Acute cholecystitis. In Cameron JL (ed.): Current Surgical Therapy, 7th Edition. St. Louis: Mosby, 2001, 423-434.
  3. Vollmer CM, Strasberg SM. Surgical diseases of the liver. In Doherty GM, Lowney J, Mason J, Reznick S, Smith M (eds.): Washington Manual of Surgery, 3rd Edition. Philadelphia: Lippincott Williams & Wilkins, 2002, 307-321.
  4. Vollmer CM, Strasberg SM. The biliary tract. In Doherty GM, Lowney J, Mason J, Reznick S, Smith M (eds.): Washington Manual of Surgery, 3rd Edition. Philadelphia: Lippincott Williams & Wilkins, 2002, 322-337.
  5. Vollmer CM, Callery MP. Commentary on Chap. 14 “Laparoscopic Staging” by Tucker ON, Conlon KC. [Editorial] In Von Hoff DD, Evans DB, Hruban RH (eds.): Pancreatic Cancer. Boston: Jones & Bartlett, 2004, 222-223.
  6. Shah SA, Vollmer CM, Callery MP. Reoperative pancreaticoduodenal surgery. In Callery MP (ed.): Handbook of Reoperative Surgery, 1st Edition. Malden, MA: Blackwell Pub., 2005, 115-134.
  7. Callery MP, Vollmer CM. Ultrasonography by surgeons. In Fischer JE (ed.): Mastery of Surgery, 5th Edition. Philadelphia: Lippincott Williams & Wilkins, 2006, 166-179.
  8. Vollmer CM. Necrosectomy for acute necrotizing pancreatitis. In Fischer JE (ed.): Mastery of Surgery, 5th Edition. Philadelphia: Lippincott Williams & Wilkins, 2006, 1268-1276.
  9. Vollmer CM. Biliary bypass. [Editorial] In Jones DB, Maithel SK, Schneider BE (eds.): Atlas of Minimally Invasive Surgery. Woodbury, CT: Cine-Med Inc., 2006, 95-97.
  10. Vollmer CM, Pratt W, Callery MP. Response to Letter to the Editor regarding “Clinical and Economic Validation of the International Study Group of Pancreatic Fistula (ISGPF) Classification Scheme.” Annals of Surgery 2007; 246(5): 910.
  11. Vollmer CM, Callery MP. Biliary injury following laparoscopic cholecystectomy: Why still a problem? Selected Summary for Gastroenterology 2007; 133:1039-1041.
  12. Ross P, Vollmer CM, Goldsmith J, Pedrosa I, Sawhney M, Brown A, Callery MP. Non-dysplastic mucinous cysts (NDMC) of the pancreas. Proceedings of Pancreas Cancer 2008. Published in Pancreatology 2008; 8:159–192.
  13. Mahadevan A, Goldstein M, Jain S, Callery MP, Vollmer CM. Cyberknife radiosurgery for pancreatic cancer. Proceedings of Pancreas Cancer 2008. Published in Pancreatology 2008; 8:159–192.
  14. Pratt W, Callery MP, Vollmer CM. Predictive risk factors for development of pancreatic fistula utilizing the ISGPF Classification Scheme. Proceedings of Pancreas Cancer 2008. Published in Pancreatology 2008; 8:159–192.
  15. Maithel S, Vollmer CM. What is the best approach to nutrition for acute pancreatitis? Chap. 6 in Tenner S, Brown A, Gress F (ed.): Curbside Consultation for the Pancreas: 49 Clinical Questions. Thorofare, NJ: Slack Inc., 2009, 25-28.
  16. Maithel S, Vollmer CM. How do I evaluate for and treat patients with autoimmune pancreatitis? Chap. 49 in Tenner S, Brown A, Gress F (eds.): Curbside Consultation for the Pancreas: 49 Clinical Questions. Thorofare, NJ: Slack Inc., 2009, 237-240.
  17. Vollmer CM, Kent TS, Callery MP. Unusual pancreatic tumors. In Cameron JL (ed.): Current Surgical Therapy, 10th Edition. St. Louis: Mosby, 2010, 444-449.
  18. Vollmer CM, Mahadevan A, Kent TS, Callery MP. Cyberknife radiotherapy extends survival for patients with margin-positive pancreatic cancer. Proceedings of Academic Surgical Congress/Society of University Surgeons Meeting 2010. Published in Journal of Surgical Research 2010; 158(2):396-397.
  19. Vollmer CM, Callery MP. Open surgical approaches to pancreatic pseudocyst drainage. In Adams RB (ed.): Atlas of Hepatobiliary and Pancreatic Surgery, 1st Edition. Philadelphia: Elsevier, 2011 (in press).
  20. Nadag S, Vollmer CM. Post-cholecystectomy problems. In Jarnigan W (ed.): Blumgart’s Surgery of the Liver, Biliary Tract, and Pancreas, 5th Edition. Philadelphia: WB Saunders Elsevier, 2011 (in press).
  21. Vollmer CM. Incidentally, it’s still cancer. Invited critique of “Implications of incidentally-discovered nonfunctioning pancreatic endocrine tumors: Short and long-term outcomes in 139 resected patients". Archives of Surgery 2011; 146(5):539.
  22. Brady CM, Vollmer CM. and Maithel SK. Common Bile Duct Exploration. In Jones D, Andrews R, Critchlow J, and  Schneider B (ed.): Minimally Invasive Surgery: Laparoscopy, Therapeutic Endoscopy, and NOTES. London: JP Medical Ltd (In press).
  23. Datta, J and Vollmer CM. Pancreas Cancer. In Zyromski NJ, ed. Handbook of Pancreas and Hepatobiliary Surgery. First Edition. Lippincott, Williams & Wilkins, 2013. (In Press)
  24. Vollmer CM. Pancreaticoduodenectomy: Pancreaticojejunostomy. In Mulholland M, Albo D, Englesbe M, Hawn M, Hughes S, Sabel M, and Dalman R, eds. Operative Techniques in Surgery. First Edition. Lippincott Williams & Wilkins, 2014 (In Press)
Alternative Media
  1. Vollmer CM, Dixon E, Cattral MS, Grant DR, Taylor BR, Gallinger S, Greig PD. Demonstration of the hydro-jet technique for hepatic parenchymal dissection. 4th Biennial Americas Hepato-Pancreato-Biliary Congress. Miami Beach, FL, Feb. 2003.
  2. Villegas L, Walcott R, Claros L, Vollmer CM. Retrograde laparoscopic cholecystectomy for xanthogranulomatous cholecystitis. 7th American Hepato-Pancreato-Biliary Annual Congress, Miami, FL, Mar. 11, 2006.
  3. Afdhal NF, Vollmer CM. Complications of laparoscopic cholecystectomy. In Rose BD (ed.): UpToDate, Waltham, MA, published on-line, 2006 - present.
  4. Vollmer CM. Surgical treatment of esophageal cancer. Patient care guidelines revised for the Society for Surgery of the Alimentary Tract (SSAT); published in Journal of Gastrointestinal Surgery 2007; 11:1216-18.
  5. Vollmer CM. Cystic neoplasms of the pancreas. Patient care guidelines developed for Society for Surgery of the Alimentary Tract (SSAT); published in Journal of Gastrointestinal Surgery 2007; 11:1225-1227.
  6. Vollmer CM. Surgical repair of incisional hernias. Patient care guidelines revised for the Society for Surgery of the Alimentary Tract (SSAT); published in Journal of Gastrointestinal Surgery 2007; 11:1231-1232.
  7. Kent TS, Pedrosa I, Sheth S, Brown A, Callery MP, Vollmer CM. Functional MR imaging of pancreatic disease. Video presentation at the SSAT meeting for Digestive Disease Week 2008, San Diego, CA, May 19, 2008.
  8. Vollmer CM. Appendicitis. Patient care guidelines developed for Society for Surgery of the Alimentary Tract (SSAT) 2008.
  9. Zakko SF, Afdhal NF, Vollmer CM. Treatment of acute cholecystitis. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, published on-line, 2011-present.

Dr. Charles Vollmer

 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine